Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

Supreme Industries Results Review - Inventory gains bolsters margin! - HDFC Securities

Posted On: 2021-05-04 12:21:14 (Time Zone: UTC)


Supreme Industries (SIL) reported a strong 4QFY21, led by strong realisations and inventory gains. Consolidated net sales/EBITDA/APAT grew 13/27/44% QoQ (46/86/284% YoY) to INR 20.8/5.1/4.5bn respectively and EBITDAM came in at an all-time high of 24.5%. We like SIL for its steady growth, market share gains, lean working capital, and sustained high return ratios. We retain our ADD rating with a revised target price of INR 2,245 (19x Mar'23E consolidated EBITDA and 30% holding in Supreme Petrochem at 30% disc to current MCap).

4QFY21 performance: SIL's volume remained flat QoQ (+8% YoY) to 111.2KT as last 10days of 4Q's demand was hit by COVID 2.0. Volume for Piping segment fell 2% YoY as demand from agri -sector declined due to high product prices. Demand from other segments was robust (+45/40/12% YoY for Industrial/Packaging/Furniture divisions). PVC-resin prices kept soaring in 4Q, resulting in NSR uptick of 16/38% QoQ/YoY. Large inventory gains (~4% of net sales) burgeoned EBITDAM to 24.5% (+267/534bps QoQ/YoY).

FY21 performance and outlook: Sales volume declined by 1% YoY to 409.1KT as demand from Piping/Furniture segments declined 2/11% YoY. However, demand from Industrial/Packaging continued to grow (+7/7% YoY). NSR grew 15% YoY to INR 153/Kg. EBITDAM grew to 20.2% (+506bps YoY) on strong inventory gains of ~3% of sales (mainly in 2H). APAT grew 109% YoY on lower tax rate and increased profit share from associates. SIL expects to add ~40KT (Ex-Odisha and TN) in FY22E, incurring a Capex of INR 4bn (INR 2bn carried forward) to cater to increased demand. Cash Conversion Cycle has improved to 29days vs 43days YoY. Net cash stands at INR 7.4bn (vs net debt 2.1bn YoY). Capex stood at INR 2.2bn vs 2.4bn YoY. Factoring in better margins, we upgrade our EBITDA estimates by 6/5% for FY22/23E.

Shares of SUPREME INDUSTRIES LTD. was last trading in BSE at Rs.2130.75 as compared to the previous close of Rs. 2113.3. The total number of shares traded during the day was 24065 in over 3468 trades.

The stock hit an intraday high of Rs. 2213.65 and intraday low of 2110.25. The net turnover during the day was Rs. 52438824.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.


Other Headlines:

Maintain BUY on CreditAccess Grameen - Accelerated write-offs dents earnings - HDFC Securities

Sundram Fasteners Q4 Results Review - HDFC Securities

SRF - Specialty Chemicals continues to shine! - HDFC Securities

Realtors welcome RBI latest stance, expect relief initiatives in next announcement

CreditAccess Grameen - Q4FY21 Result Update - ICICI Securities

JM Financial - Exits FY21 with well contained stress pool; sequential AUM uptick encouraging - ICICI Securities

Hero MotoCorp - Margins remain resilient - ICICI Securities

CEAT - Margin pressures likely to intensify - ICICI Securities

SRF Limited - FY22E growth capped on higher plants utilisation - ICICI Securities

I-direct Instinct - Automotive Axles - ICICI Direct

Quant Pick - Axis Bank - ICICI Direct

Gladiator Stocks - Caplin Point Laboratories - ICICI Direct

Q4FY21 Result Update - Coforge Ltd - ICICI Direct

Tata Consumer Products - Q4FY21 First Cut - ICICI Direct

Coforge Ltd - Q4FY21 Result Update - YES Securities

CreditAccess Grameen - Q4FY21 Result Update - YES Securities

Blue Star - Q4 FY21 first cut - Inline performance - YES Securities

Tata Consumer - 4QFY21 results first cut - YES Securities

Tata Consumer 4QFY21 results first cut - YES Securities

Maintain BUY on CDSL - Strong growth momentum - HDFC Securities

Maintain ADD on L&T Infotech - Steady progression - HDFC Securities

Blue Dart Express - Q4FY21 - The bulge continues - ICICI Securities

Tata Steel - FY22E Net Debt/EBITDA at <1x - ICICI Securities

Larsen & Toubro Infotech - Consistency continues! - ICICI Securities

CEAT - Decent quarter; new capex likely to curtail FCF - ICICI Securities

Q4FY21 Result Update - Alembic Pharma - ICICI Direct

Gladiator Stocks - Cadila Healthcare - ICICI Direct

Q4FY21 Result Update - Larsen & Toubro Infotech - ICICI Direct

RBI Action Update - May 2021 - ICICI Direct

Quant Pick - Aurobindo Pharma - ICICI Direct

Q4FY21 Result Update - Greaves Cotton - ICICI Direct

Adani Total Gas Ltd - Q4FY21 Result Update - YES Securities

L&T Infotech - Q4FY21 Result Update - YES Securities

Bluedart Express - Q4 FY21 first cut - Miss on topline; Profitability improves - YES Securities

Views on the announcement by RBI Governor - Ms. Bekxy Kuriakose, Head - Fixed Income, Principal Asset Management

Views from experts on RBI announcement - May 5, 2021

Maintain REDUCE on RBL Bank - Elevated retail slippages continue - HDFC Securities

Resolution 2.0 measure by RBI to provide relief to real estate linked SME stakeholders

Godrej Properties - Robust quarter; positives fairly priced in - HDFC Securities

RBI Relief 2.0 - May 2021 - Acuité Ratings & Research

MDF Industry - Countervailing duty on MDF recommended; imports may get hit structurally - ICICI Securities

Home First Finance Company - Core earnings steady; profitability buoyed by securitisation income - ICICI Securities

RBL Bank - Modest return profile in the interim; transitioning underway - ICICI Securities

Alembic Pharmaceuticals - US continues to be under pressure - ICICI Securities

Q4FY21 Result Update - SBI Life Insurance - ICICI Direct

Q1CY21 Result Update - Varun Beverages - ICICI Direct

RBL Bank: Views from leading research houses on Q4FY21 results

Q4FY21 Result Update - Supreme Industries - ICICI Direct

Q4FY21 Result Update - Tata Chemicals - ICICI Direct

Larsen & Toubro Infotech - Q4FY21 First Cut - ICICI Direct


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020